- Home
- DCGO vs DXR Comparison
DCGO vs DXR Comparison
Compare DCGO & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DCGO | DXR |
|---|---|---|
| Founded | 2015 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.0M | 69.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DCGO | DXR |
|---|---|---|
| Price | $0.70 | $12.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $3.33 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 874.8K | 6.9K |
| Earning Date | 02-26-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.46 |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $368,093,385.00 | $66,306.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $34.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.66 | $6.55 |
| 52 Week High | $5.68 | $14.76 |
Technical Indicators
Market Signals| Indicator | DCGO | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 30.80 | 42.78 |
| Support Level | $0.74 | $12.08 |
| Resistance Level | $0.80 | $12.79 |
| Average True Range (ATR) | 0.06 | 0.57 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 11.37 | 18.50 |
Price Performance
Historical ComparisonAbout DCGO DocGo Inc.
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has three reporting segments: Mobile Health Services, Transportation Services, and Corporate. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.